Core Laboratories N.V. logo CLB - Core Laboratories N.V.

Price: -- -- | CONSENSUS: Hold DETAILS
STRONG
BUY
0
BUY 16
HOLD 17
SELL 4
STRONG
SELL
0
| PRICE TARGET: $25.00 DETAILS
HIGH: $32.00
LOW: $17.00
MEDIAN: $26.00
CONSENSUS: $25.00
UPSIDE: 75.81%
AlphaVal

AlphaVal

Deterministic, archetype-aware fair value

Oil & Gas E&P 85% confidence

Primary model: FCF at Price Deck × Multiple

Valuation Signal Overvalued Strong
Trading 55.0% above fair value
Current Price $14.22
Bear Case $0.00 100.0% downside ($0.00 - $14.22) / $14.22 = -100.0% FCF $18M × 10x
Fair Value $9.17 35.5% downside ($9.17 - $14.22) / $14.22 = -35.5% FCF $23M × 13x
Bull Case $21.57 51.7% upside ($21.57 - $14.22) / $14.22 = 51.7% FCF $28M × 16x

Adjust Assumptions

75.0$/bbl
13.0x

Key Value Driver

Oil price assumption ($75/bbl base case)

Implied Market Multiple 37.1x

Plain-Language Summary

Our base-case estimate uses a valuation based on free cash flow under different commodity price assumptions and a valuation multiple. We then blend that result with the average analyst price target of $25.00 from 37 analysts, using a 30% weight on analyst consensus. That produces an estimated intrinsic value of $9.17 per share.

Warnings

If oil drops to $60/barrel, the stock could fall -100%. Check whether the company can survive at low prices and still pay its dividend.
Where you think oil prices will settle long-term drives over 80% of this valuation. The biggest risk isn't the company itself — it's getting the commodity price wrong.
Wall Street's average price target is $25.00 (from 37 analysts). Our estimate is 90% below the consensus -- consider that gap carefully.

Key Risks

  • Growth DCF inappropriate — commodity volumes do not compound
  • Geopolitical premiums are real but historically temporary
  • Reserve replacement ratio below 100% for 3 years is existential